TY - JOUR
T1 - Aortic Dissection in Patients With Genetically Mediated Aneurysms
T2 - Incidence and Predictors in the GenTAC Registry
AU - on behalf of the GENTAC Registry Investigators
AU - Weinsaft, Jonathan W.
AU - Devereux, Richard B.
AU - Preiss, Liliana R.
AU - Feher, Attila
AU - Roman, Mary J.
AU - Basson, Craig T.
AU - Geevarghese, Alexi
AU - Ravekes, William
AU - Dietz, Harry C.
AU - Holmes, Kathryn
AU - Habashi, Jennifer
AU - Pyeritz, Reed E.
AU - Bavaria, Joseph
AU - Milewski, Karianna
AU - LeMaire, Scott A.
AU - Morris, Shaine
AU - Milewicz, Dianna M.
AU - Prakash, Siddharth
AU - Maslen, Cheryl
AU - Song, Howard K.
AU - Silberbach, G. Michael
AU - Shohet, Ralph V.
AU - McDonnell, Nazli
AU - Hendershot, Tabitha
AU - Eagle, Kim A.
AU - Asch, Federico M.
N1 - Funding Information:
GenTAC supported by National Heart, Lung, and Blood Institute and National Institute of Arthritis, Musculoskeletal and Skin Diseases (HHSN268200648199C, HHSN268201000048C). Dr. LeMaire is a member of the Advisory Board for Baxter Healthcare; the clinical study principal investigator for Vascutek Terumo and Baxter Healthcare; and a clinical trial co-investigator for Medtronic, W.L. Gore & Associates, and GlaxoSmithKline. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Publisher Copyright:
© 2016 American College of Cardiology Foundation
PY - 2016
Y1 - 2016
N2 - Background Aortic dissection (AoD) is a serious complication of thoracic aortic aneurysm (TAA). Relative risk for AoD in relation to TAA etiology, incidence, and pattern after prophylactic TAA surgery are poorly understood. Objectives This study sought to determine the incidence, pattern, and relative risk for AoD among patients with genetically associated TAA. Methods The population included adult GenTAC participants without AoD at baseline. Standardized core laboratory tests classified TAA etiology and measured aortic size. Follow-up was performed for AoD. Results Bicuspid aortic valve (BAV) (39%) and Marfan syndrome (MFS) (22%) were the leading diagnoses in the studied GenTAC participants (n = 1,991). AoD occurred in 1.6% over 3.6 ± 2.0 years; 61% of AoD occurred in patients with MFS. Cumulative AoD incidence was 6-fold higher among patients with MFS (4.5%) versus others (0.7%; p < 0.001). MFS event rates were similarly elevated versus those in patients with BAV (0.3%; p < 0.001). AoD originated in the distal arch or descending aorta in 71%; 52% of affected patients, including 68% with MFS, had previously undergone aortic grafting. In patients with proximal aortic surgery, distal aortic size (descending thoracic, abdominal aorta) was larger among patients with AoD versus those without AoD (both p < 0.05), whereas the ascending aorta size was similar. Conversely, in patients without previous surgery, aortic root size was greater in patients with subsequent AoD (p < 0.05), whereas distal aortic segments were of similar size. MFS (odds ratio: 7.42; 95% confidence interval: 3.43 to 16.82; p < 0.001) and maximal aortic size (1.86 per cm; 95% confidence interval: 1.26 to 2.67; p = 0.001) were independently associated with AoD. Only 4 of 31 (13%) patients with AoD had pre-dissection images that fulfilled size criteria for prophylactic TAA surgery at a subsequent AoD site. Conclusions Among patients with genetically associated TAA, MFS augments risk for AoD even after TAA grafting. Although increased aortic size is a risk factor for subsequent AoD, events typically occur below established thresholds for prophylactic TAA repair.
AB - Background Aortic dissection (AoD) is a serious complication of thoracic aortic aneurysm (TAA). Relative risk for AoD in relation to TAA etiology, incidence, and pattern after prophylactic TAA surgery are poorly understood. Objectives This study sought to determine the incidence, pattern, and relative risk for AoD among patients with genetically associated TAA. Methods The population included adult GenTAC participants without AoD at baseline. Standardized core laboratory tests classified TAA etiology and measured aortic size. Follow-up was performed for AoD. Results Bicuspid aortic valve (BAV) (39%) and Marfan syndrome (MFS) (22%) were the leading diagnoses in the studied GenTAC participants (n = 1,991). AoD occurred in 1.6% over 3.6 ± 2.0 years; 61% of AoD occurred in patients with MFS. Cumulative AoD incidence was 6-fold higher among patients with MFS (4.5%) versus others (0.7%; p < 0.001). MFS event rates were similarly elevated versus those in patients with BAV (0.3%; p < 0.001). AoD originated in the distal arch or descending aorta in 71%; 52% of affected patients, including 68% with MFS, had previously undergone aortic grafting. In patients with proximal aortic surgery, distal aortic size (descending thoracic, abdominal aorta) was larger among patients with AoD versus those without AoD (both p < 0.05), whereas the ascending aorta size was similar. Conversely, in patients without previous surgery, aortic root size was greater in patients with subsequent AoD (p < 0.05), whereas distal aortic segments were of similar size. MFS (odds ratio: 7.42; 95% confidence interval: 3.43 to 16.82; p < 0.001) and maximal aortic size (1.86 per cm; 95% confidence interval: 1.26 to 2.67; p = 0.001) were independently associated with AoD. Only 4 of 31 (13%) patients with AoD had pre-dissection images that fulfilled size criteria for prophylactic TAA surgery at a subsequent AoD site. Conclusions Among patients with genetically associated TAA, MFS augments risk for AoD even after TAA grafting. Although increased aortic size is a risk factor for subsequent AoD, events typically occur below established thresholds for prophylactic TAA repair.
KW - Marfan syndrome
KW - aortic aneurysm
KW - aortic dissection
KW - bicuspid aortic valve
UR - http://www.scopus.com/inward/record.url?scp=84978208872&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84978208872&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2016.03.570
DO - 10.1016/j.jacc.2016.03.570
M3 - Article
C2 - 27282895
AN - SCOPUS:84978208872
SN - 0735-1097
VL - 67
SP - 2744
EP - 2754
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 23
ER -